Total
0
Shares
Dr Arthur Martin joins Holista CollTech’s (ASX:HCT) Scientific Advisory Board
  • Holista CollTech (HCT) has appointed Dr Arthur v. Martin to its Scientific Advisory Board
  • Arthur is currently the President and Principal Research Scientist of South Carolina based Global Infection Control Consultants and is behind the technology in Path-Away
  • Path-Away is an all-natural active ingredient that has been proven to be effective as a broad spectrum sanitizer
  • Holista currently has distribution rights for Path-Away in South East Asia, the United Kingdom and Europe
  • Holista is up 16.5 per cent on the market this morning, selling shares for 16.5¢ apiece

Holista CollTech (HCT) has appointed Dr Arthur v. Martin to its Scientific Advisory Board.

Arthur is currently the President and Principal Research Scientist of South Carolina based Global Infection Control Consultants (GICC LLC) and is behind the technology in Path-Away.

He graduated from the New England Institute of Technology where he studied HVAC (Heating, Ventilation and Air Conditioning) and Refrigeration Engineering.

Under his leadership, GICC LLC developed Path-Away, an all-natural active ingredient that has been proven to be effective as a broad spectrum sanitizer.

Holista currently has distribution rights for Path-Away in South East Asia, the United Kingdom and Europe. Sales of a sanitiser using Path-Away have increased significantly in Malaysia since the start of the year, following the coronavirus outbreak.

The Scientific Advisory Board is run by Roscoe Moore, a retired U.S. Deputy Surgeon General and earlier this month, Roscoe was appointed to the 'Corona Virus Task Force'.

“I have been working with Dr Rajen and Holista for 15 years," Arthur said.

"I humbly accept this appointment as scientific advisor to Holista and hope to bring my knowledge and expertise to use Path-Away to improve protection worldwide against viruses and the flu," he added.

CEO Dr Rajen Manicka is thrilled to have Arthur join the Scientific Advisory Board.

"We intend to leverage on his network and expertise to increase the range of products and services using Path-Away. This will be a big boost to our sales and marketing efforts with Path-Away," he said.

GICC LLC has designed specialised equipment and processes to use Path-Away to
improve the air quality and safety of buildings such as airports, transportation hubs, hospitals, schools and factories worldwide.

Holista is up 16.5 per cent on the market this morning, selling shares for 16.5¢ apiece at 11:23 am AEDT.


Subscribe


HCT by the numbers
More From The Market Herald
Myfiziq (ASX:MYQ)-CEO, Vlado Bosanac - The Market Herald

" MyFiziq (ASX:MYQ) opportunity knocks for online body scanning tech

Body scanning tech provider, MyFiziq (MYQ) has reported a flurry of business activity as COVID-19 lockdowns and needs for telehealth services open up
Cellmid (ASX:CDY)- CEO, Maria Halasz - The Market Herald

" Cellmid (ASX:CDY) shares triple with COVID-19 test kit deal

Haircare specialist Cellmid (CDY) has started dabbling in coronavirus-related business and promptly tripled its share price today.
BOD Australia (ASX:BOD) - CEO, Jo Patterson - The Market Herald

" Bod Australia (ASX:BDA) and Swisse launch hemp product range

Medicinal cannabis company Bod Australia (BDA) has launched nine hemp-based products in collaboration with Swisse Wellness.
LBT Innovations (ASX:LBT) - CEO, Brent Barnes - The Market Herald

" LBT Innovations (ASX:LBT) applies for fresh FDA approval for APAS

Medical artificial intelligence specialist LBT Innovations (LBT) is eyeing fresh U.S. Food and Drug Administration (FDA) approval for its plate assessment device.